Previous 10 | Next 10 |
2024-01-30 08:30:28 ET More on Pre-market losers & stocks. Borr Drilling: Still Undervalued, But The Easy Money Has Already Been Made Borr Drilling: Jackup Market Expected To Remain Strong - Buy Borr Drilling Limited (BORR) Q3 2023 Earnings Call Transcript ...
2024-01-29 13:21:09 ET Gainers: Neximmune ( NEXI ) +94% . Palisade Bio PALI +83% . Rail Vision Ltd ( RVSN ) +68% . Revelation Biosciences ( REVB ) +54% . Mercurity Fintech Holding MFH +34% . J-Long Group Ltd JL +29% . Intelli...
2024-01-29 10:00:02 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Investors were most bullish on H...
2024-01-29 08:28:44 ET Revelation Biosciences ( REVB ) +69% . TuanChe ( TC ) +38% . Spectral AI ( MDAI ) +38% . Hub Cyber Security ( HUBC ) +34% . Cadrenal Therapeutics ( CVKD ) +14% . J-Long Group ( JL ...
2024-01-23 09:02:32 ET More on Revelation Biosciences Seeking Alpha’s Quant Rating on Revelation Biosciences Read the full article on Seeking Alpha For further details see: Revelation Biosciences to implement a 1-for-30 reverse split
Revelation Biosciences Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), announced today that, on January 25, 2024, the Company will implement a 1-for-30 reverse split of its common stock following approval at its Special Meeting of Stockholders held on January 17, ...
2023-11-14 02:59:25 ET More on Revelation Biosciences Seeking Alpha’s Quant Rating on Revelation Biosciences Historical earnings data for Revelation Biosciences Financial information for Revelation Biosciences For further details see: Revelation Bi...
Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, today reported its three and nine months ended September 30, 20...
Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...
Revelation Biosciences Inc. (REVB) is expected to report $-0.3 for Q3 2023
News, Short Squeeze, Breakout and More Instantly...
Revelation Biosciences Inc. Company Name:
REVB Stock Symbol:
OTCMKTS Market:
Revelation Biosciences Inc. Website:
2024-06-25 06:18:00 ET 3 Ways That the 2024 Election Can Impact Penny Stocks Elections can significantly influence financial markets, including the domain of penny stocks . Penny stocks, often traded below five dollars per share, present a unique opportunity for investors aiming for...
A look at the top 10 most actives in the United States Agrify Corporation (AGFY) rose 164.2% to $0.6658 on volume of 125,460,313 shares NVIDIA Corporation (NVDA) fell 2.9% to $122.88 on volume of 51,163,891 shares Crown Electrokinetics Corp. (CRKN) fell 0.3% to $0.04097 on volume of 44,45...
-Top-line data forthcoming- Revelation Biosciences, Inc. (NASDAQ: REVB) (the “Company” or “Revelation”), a clinical-stage life sciences company that is focused on harnessing the power of trained immunity for the prevention and treatment of disease, announced ...